BlackRock’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$331M Sell
2,913,741
-6,494
-0.2% -$738K 0.01% 1296
2025
Q1
$307M Sell
2,920,235
-25,849
-0.9% -$2.72M 0.01% 1322
2024
Q4
$316M Sell
2,946,084
-53,548
-2% -$5.74M 0.01% 1389
2024
Q3
$300M Buy
2,999,632
+128,136
+4% +$12.8M 0.01% 1410
2024
Q2
$242M Buy
2,871,496
+3,226
+0.1% +$272K 0.01% 1493
2024
Q1
$210M Sell
2,868,270
-94,044
-3% -$6.87M ﹤0.01% 1602
2023
Q4
$212M Buy
2,962,314
+121,230
+4% +$8.66M 0.01% 1601
2023
Q3
$170M Sell
2,841,084
-65,075
-2% -$3.9M ﹤0.01% 1636
2023
Q2
$210M Buy
2,906,159
+67,497
+2% +$4.87M 0.01% 1532
2023
Q1
$209M Buy
2,838,662
+48,898
+2% +$3.6M 0.01% 1495
2022
Q4
$186M Sell
2,789,764
-1,483,222
-35% -$99.1M 0.01% 1585
2022
Q3
$230M Sell
4,272,986
-62,884
-1% -$3.38M 0.01% 1360
2022
Q2
$241M Sell
4,335,870
-45,621
-1% -$2.54M 0.01% 1377
2022
Q1
$307M Sell
4,381,491
-15,230
-0.3% -$1.07M 0.01% 1336
2021
Q4
$424M Buy
4,396,721
+18,617
+0.4% +$1.79M 0.01% 1160
2021
Q3
$381M Buy
4,378,104
+1,100,966
+34% +$95.7M 0.01% 1204
2021
Q2
$268M Sell
3,277,138
-131,454
-4% -$10.8M 0.01% 1543
2021
Q1
$324M Buy
3,408,592
+257,100
+8% +$24.5M 0.01% 1361
2020
Q4
$196M Sell
3,151,492
-272,692
-8% -$16.9M 0.01% 1625
2020
Q3
$204M Buy
3,424,184
+13,553
+0.4% +$806K 0.01% 1366
2020
Q2
$238M Sell
3,410,631
-129,652
-4% -$9.05M 0.01% 1229
2020
Q1
$161M Sell
3,540,283
-283,125
-7% -$12.8M 0.01% 1319
2019
Q4
$249M Sell
3,823,408
-118,218
-3% -$7.69M 0.01% 1312
2019
Q3
$245M Sell
3,941,626
-64,119
-2% -$3.98M 0.01% 1252
2019
Q2
$285M Sell
4,005,745
-385,281
-9% -$27.4M 0.01% 1156
2019
Q1
$344M Sell
4,391,026
-36,237
-0.8% -$2.84M 0.02% 1006
2018
Q4
$375M Sell
4,427,263
-937,026
-17% -$79.3M 0.02% 822
2018
Q3
$919M Buy
5,364,289
+130,536
+2% +$22.4M 0.04% 452
2018
Q2
$676M Buy
5,233,753
+402,585
+8% +$52M 0.03% 555
2018
Q1
$498M Buy
4,831,168
+27,041
+0.6% +$2.79M 0.02% 705
2017
Q4
$410M Buy
4,804,127
+82,168
+2% +$7.02M 0.02% 821
2017
Q3
$401M Buy
4,721,959
+419,699
+10% +$35.6M 0.02% 798
2017
Q2
$326M Buy
4,302,260
+110,426
+3% +$8.36M 0.02% 922
2017
Q1
$277M Buy
4,191,834
+4,189,319
+166,573% +$277M 0.02% 1032
2016
Q4
$159K Sell
2,515
-576
-19% -$36.4K ﹤0.01% 2232
2016
Q3
$197K Sell
3,091
-4,603
-60% -$293K ﹤0.01% 2121
2016
Q2
$572K Buy
7,694
+5,480
+248% +$407K ﹤0.01% 1593
2016
Q1
$147K Buy
2,214
+1,379
+165% +$91.6K ﹤0.01% 1776
2015
Q4
$56K Sell
835
-255
-23% -$17.1K ﹤0.01% 1957
2015
Q3
$59K Sell
1,090
-9,604
-90% -$520K ﹤0.01% 1815
2015
Q2
$673K Buy
10,694
+9,607
+884% +$605K ﹤0.01% 1450
2015
Q1
$52K Sell
1,087
-1,055
-49% -$50.5K ﹤0.01% 1902
2014
Q4
$71K Buy
2,142
+1,267
+145% +$42K ﹤0.01% 1796
2014
Q3
$26K Hold
875
﹤0.01% 2156
2014
Q2
$34K Sell
875
-133
-13% -$5.17K ﹤0.01% 2062
2014
Q1
$43K Buy
1,008
+304
+43% +$13K ﹤0.01% 1954
2013
Q4
$23K Sell
704
-46
-6% -$1.5K ﹤0.01% 2258
2013
Q3
$20K Hold
750
﹤0.01% 2257
2013
Q2
$18K Buy
+750
New +$18K ﹤0.01% 2337